C hronic musculoskeletal pain (CMP) conditions are ranked in the top 10 global burden of disease, with low back pain (LBP) identified as the leading cause of disability globally. 1, 2 Chronic musculoskeletal pain has been simply defined as pain in the bones and joints of the body, which may be the result of a musculoskeletal disease, injury, or the cause may not be known. 3 It is generally characterized by pain and loss of physical function, and includes conditions such as LBP, osteoarthritis (OA), chronic knee pain, and fibromyalgia. 3, 4 Chronic musculoskeletal pain conditions contribute to lost productivity and increased use of health care resources while also inflicting considerable burden on individuals and their families, due to a reduced ability to maintain activities of daily living. 5 Self-management is a treatment approach that encourages individuals to take a more proactive role in the care of their condition through lifestyle and behavioral changes, and appropriate interaction with health care services. 6 It is a widely recognized and recommended approach to treating CMP and provides patients with the knowledge, skills, and capabilities to care for their long-term condition. 7, 8 Economic Evaluation of Self-Management Previous reviews have found a lack of consensus on the cost-effectiveness of self-management interventions for CMP. 9, 10 Pinto et al, 9 in a review of nonpharmacological treatments for OA, found that lifestyle interventions that promote self-management were not cost-effective when health outcomes were measured in quality-adjusted life-years (QALYs). 9 The included studies found that the interventions had higher costs than the comparator with no improvement in QALYs; yet some of the studies found a positive difference in a disease-specific measure of effect (eg, Western Ontario and McMaster Universities Arthritis Index) in favor of the intervention. In the same review, rehabilitation interventions that combined exercise and education to promote self-management had variable cost-effectiveness results. 9 Of the 3 studies identified, only 1 was deemed to be cost-effective using conventional economic evaluation methods. 9 Another study found that the self-management intervention was more expensive and showed no improvement in QALYs, yet showed a positive change in pain or disability 9 ; and the third rehabilitation study found the intervention was cheaper but resulted in QALY losses. 9 In a second review of guideline-endorsed treatments for LBP, the cost-effectiveness of self-management advice interventions also varied, even for similar interventions with similar comparators. 10 The review highlighted that methodological flaws regarding the identification and measurement of costs were apparent, which made the reliability of findings questionable. Specifically, it briefly noted that some important costs were omitted from analyses; however, it did not provide specific details on those costs and the measurements used to capture them. 10 Similar research exploring cost-effectiveness analyses (CEAs) in musculoskeletal disease also identified a lack of consistent costing and recommended a standardized costing matrix for future economic evaluations. 11, 12 However, this research did not focus specifically on CMP conditions or on evaluations of self-management. Accordingly, the literature makes it clear that further exploration of methodological issues in CEAs of self-management is required to establish consensus on the cost-effectiveness of these interventions.
An important aspect of conducting a rigorous economic evaluation is the application of the appropriate analytical perspective, as this determines the categories of costs and effects included in the analysis. 13, 14 It is common in economic evaluations of health care interventions to limit the analysis to the health service perspective, which is defined as "a viewpoint for conducting a cost-effectiveness analysis that includes formal health care sector (medical) costs borne by third-party payers and paid out-of-pocket by patients. These third-party and out-of-pocket medical costs include current and future costs, related and unrelated to the condition under consideration." 15 Many national CEA guidelines recommend applying a health service perspective, for example Ireland, the United Kingdom, and France. [14] [15] [16] Others recommend the application of a broader societal perspective, [17] [18] [19] [20] which is defined as "a viewpoint for conducting a cost-effectiveness analysis that incorporates all costs and health effects regardless of who incurs the costs and who obtains the effects." 15 The rationale for applying one perspective over the other is debated throughout health economic literature. [21] [22] [23] The choice of perspective is of greater importance when the difference in CEA results are substantial between perspectives. Such differences can be large when a significant proportion of costs and benefits accrue outside of the health system. Self-management for CMP may be an example of such interventions, as a key aim of self-management is to shift the day-to-day management of the condition more toward the individual and their support system. 6 The lack of consensus on the cost-effectiveness of self-management highlights the need to explore the current level of consistency and standardization regarding outcome measurement in economic analyses of self-management interventions. Moreover, considering the ongoing debate regarding the application of the appropriate analytical perspectives in economic evaluations, efforts need to be made to utilize empirical research to improve guidelines in this area in relation to self-management. Thus, the primary aim of this systematic review was to identify how costs and effects were assessed in self-management interventions for CMP; and whether the analytical perspective chosen affects the conclusions regarding the interventions' cost-effectiveness.
Methods
The systematic review protocol was registered on PROSPERO in 2015 and is available online (CRD42015016728).
Data Sources and Searches
A systematic search of 5 databases (Ovid MEDLINE, EMBASE, CINAHL, Cochrane Register of Controlled Trials, National Health Service Economic Evaluation Database) was conducted to identify all records from the databases' inception to January 2017 relating to the costs of self-management interventions for CMP conditions. A detailed search strategy was developed and adapted for each database (eAppendix, available at https://academic.oup.com/ptj). The review included studies either written in English or other languages when an accurate translation was available. Only studies published in peer-review literature were included, thus gray literature was not surveyed. Protocol papers were also included. Authors were contacted where possible for full texts and/or further information when conference abstracts were identified. Reference lists of included studies were searched for relevant citations and included in the screening process.
Study Selection
Studies were included if they satisfied the following inclusion criteria; patients (≥18 years of age) had a primary complaint of CMP, the intervention had the primary aim of providing patients with the ability to actively manage their condition, and the study included a costing component. All types of analyses featuring costs were included (ie, costing studies, CEAs, cost-utility, cost-benefit, and cost-minimization analysis) regardless of whether they were full economic evaluations or not; this was to ensure that the review captured all relevant cost and effects included in analyses of self-management interventions. All types of study designs were included in this review. Table 1 provides a detailed description of all inclusion and exclusion criteria. All titles and abstracts retrieved were downloaded to reference management software (EndNote X7.4; Clarivate Analytics, Philadelphia, PA) and duplicates were removed. Two authors (M.H., A.H.) independently screened the references and excluded those which clearly did not meet the inclusion criteria. The 2 screeners examined the remaining citations and obtained full-text copies of potentially Table 1 .
Inclusion and Exclusion Criteria

Type of Criterion
Category Description
Inclusion Population (must satisfy a, b, or c)
Adults (≥18 years of age) with chronic musculoskeletal pain conditions described as: a) Persistent or episodic pain lasting >3 mo in the axial skeleton (neck and low back) or large peripheral joints (hip, knee, or shoulder); or b) A clinical diagnosis of chronic pain, nonspecific musculoskeletal pain, mechanical or simple low back pain, osteoarthritis, or fibromyalgia; or c) Degenerative joint disease or other related conditions that are linked to or secondary to this, such as spondylosis (vertebral osteophytes secondary to disk degeneration).
Intervention (must satisfy a and b) a) Aim: Has a primary aim, which can be explicit or implicitly implied, to provide patients with the ability to actively manage their conditions through day-to-day tasks that they must undertake to control or reduce the impact of disease (including diet, physical activity, or practicing relaxation techniques) or at-home management strategies (eg, heat/cold or transcutaneous electrical nerve stimulation machine).
b) Delivery components: Intervention must provide either education or training (or both) in management skills to enhance knowledge, skills, or psychological/social resources.
Comparator
No studies were excluded on the basis of a comparator.
Outcome Included a cost component (ie, aimed to calculate or calculated a cost or costs of some or all components of the intervention).
Study design
No studies were excluded on the basis of a study design.
Exclusion Population
Patients who have had surgery or patients on a surgical waiting list (different treatment pathway).
People with rheumatoid arthritis, osteoporosis, ankylosing spondylitis, spondylolisthesis, or other defined rheumatological problems because self-management is not a primary treatment recommendation.
Intervention
Any intervention that includes a passive modality (eg, ultrasound, acupuncture, transcutaneous electrical nerve stimulation, or hydrotherapy delivered in a supervised setting by a health care professional) as the primary intervention treatment when self-management is used as a supplementary/add-on treatment for a passive modality.
Interventions with the primary aim of changing a clinical outcome (eg, pain, function, or return to physical activity) over the stated treatment time period when delivered by a health care professional, rather than promoting long-term self-management skills.
Outcome
Did not apply a cost to at least 1 component of resource use.
(n = 13) were OA, 16% (n = 9) were a combination of at least 2 or more CMP conditions, 9% (n = 5) focused on fibromyalgia, 9% (n = 5) on knee pain, 2% (n = 1) on neck pain, and 2% (n = 1) on arthritis (type not specified). The majority of the identified studies were randomized controlled trials (84%, n = 48), [24] [25] [26] [27] [28] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] 47, 48, [51] [52] [53] [54] [55] [56] [57] 59 ,60,63-67,69-72 5% (n = 3) were cohort studies, 49, 50, 68 3% (n = 2) were nonrandomized controlled trials, 58,61 3% (n = 2) were control before-after studies, 29, 62 and 3% (n = 2) were an economic modelling study. 46, 82 The majority of studies had a follow-up period of between 6 to 12 months (75%, n = 43). Twelve (21%) studies reported a follow-up period of greater than 1 year, and the longest period of analysis reported was 10 years using simulation modeling techniques. 82 The majority of studies (68%, n = 39) stated that they conducted a costeffectiveness and/or cost-utility analysis. Others stated they conducted a cost minimization/cost analysis (23%, n = 13) or cost-benefit analysis (9%, n = 5). There were 72 self-management study arms in total among the 57 eligible articles, as some studies compared multiple self-management strategies. The majority of self-management arms were solely education-based (61%, n = 35) with varying intensities (for example, this varied from the provision of a booklet to several interactive group sessions). The second most common self-management intervention was a combination of exercise and education (42%, n = 24), followed by cognitive behavioral therapy (CBT) interventions (12%, n = 7). The remaining self-management arms were varying combinations of different techniques/approaches and the most common comparator was usual care (32%, n = 18). There was a variety of other comparators as detailed in Ta 
Economic Perspective Chosen: Societal Versus Health Service
The majority of studies (65%, n = 37) conducted the economic analysis from a vention. In studies where the economic perspective was not explicitly stated, the primary reviewer (M.H.) compiled the list of costs and outcomes captured and determined the perspective chosen based on the detailed definitions of each perspective outlined in the introduction section of this paper. As with the data extraction process, all data were checked for accuracy by a second reviewer (A.H.).
Results
In total, 9,465 records were identified through multiple database searches and reference checking; after the screening process and reference checking, a total of 57 unique studies met the inclusion criteria reported in 65 articles (Fig. 1) . 
Summary of Findings
There was substantial heterogeneity in the cost data collected and cost measurement tools used in studies of self-management interventions for CMP. The majority of studies conducted their analysis from the societal perspective (65%, n = 37), but regardless of the perspective chosen cost variables collected within each perspective were highly variable. Overall, based on the results of the 8 studies that conducted analyses from both perspectives, the economic perspective had no impact on conclusions regarding the interventions' cost-effectiveness; ie, if the intervention was deemed to be either cost-effective/ not cost-effective from one perspective, it remained so from the other perspective. Cost measurement tools varied and lacked transparency, as the majority of studies used a study-derived self-report questionnaire not previously used in other studies (53%, n = 30). There was a degree of consistency in the effects captured, in that 67% (n = 38) calculated QALYs. The reported cost-effectiveness or cost-saving results of self-management interventions also varied, which in part may be explained by the heterogeneity of the self-management interventions and comparators assessed in this review.
Study Characteristics
The characteristics of the included studies are reported in 
Data Synthesis
All data were inputted into Microsoft Excel (version 14.0.7). Study characteristics including a description of the intervention, comparison, cost measurement, measure of effect, and economic perspective were summarized for each CMP condition and organized by type of economic analysis employed. For those studies that conducted a cost analysis from both perspectives, the costs of the intervention and comparator and cost-effectiveness results were summarized from both perspectives to allow comparison of cost outcomes according to the perspective applied.
The inclusion of various cost categories was summarized as the percentage of studies capturing each cost variable within the 2 perspectives. This data was organized using 4 cost categories: (1) health care utilization, which refers to all health service cost variables that are paid for by the publicly funded health system; (2) intervention delivery, which refers to all costs associated with providing the intervention paid for by the health system/payer/research grant; (3) labor productivity, which refers to any costs or benefits associated with a change in work activity and reflects any potential income support benefits provided due to reduced work capability; and (4) costs borne by patients/families, which includes all costs imposed on the individual/families due to their condition and participation in the inter- Full-text articles identified for eligibility n=338
Records could not retrieve n=25
Full-text articles assessed for eligibility n=313
Excluded on full text n=249
Studies included in review n=64
Additional studies included from reference checking n=1
Unique studies included for data extraction n=57 have been that they did not occur in certain cases, or they were possibly considered irrelevant, or it may be that they were simply not recorded. The majority of costs were captured using study-derived questionnaires that had not been previously developed or used in other studies (53%, n = 30). Sixteen (28%) of the 57 studies used medical health records and 6 (10%) used patient-completed diaries to measure costs. Eleven (19%) studies used a named measure to collect costs, of which 9 used the Client Service Receipt Inventory (CSRI), 40 50 One study stated that self-report variables that had previously been shown to be valid were used to collect costs, but did not state whether it was a named measure. 48 Overall, the majority of studies relied on self-report measurements (58%, n = 33) to collect costs, only 9 (16%) used objective measures, and 15 (26%) used a combination of self-report and objective measures. Of the 57 studies, 22 (39%) used a combination of measurement tools to collect costs (ie, 2 or more self-report measures, or 1 or more self-report measure in addition to an objective measure).
Effects Variables and Measures
There was some variability in the measures of effect. The most common measure of health effects used to estimate QALY gains was the EuroQol EQ-5D (46%, n = 26 49, 60, 72 care utilization; 24 (65%) reported costs related to intervention delivery; and 34 (92%) collected costs due to labor productivity. All of the 34 studies that assessed labor productivity costs captured absenteeism, and 9 captured presenteeism (lost productivity while at work due to condition). 27, 33, 48, 50, 51, 70, 72, 80, 88 Other labor productivity cost variables collected were social security benefits, 40, 64 and disability pension received by the patient. 42 Finally, 22 (59%) of the 37 studies captured costs borne by the patient and/or their families. 27, 28, 31, 33, 36, 39, 40, 44, 46, 50, 51, [55] [56] [57] 60, [64] [65] [66] 70, 80, 81, 86 The most common cost borne by the patient was transportation/travel costs, outof-pocket expenses, and private health care paid for by the patient. Other costs included time spent in treatment/health promoting behavior, 27, 39, 46, 50, 55, 80 informal care, 40, 57, 64, 80 over-the-counter medication, 36, 40, 57, 65, 80, 83, 86 days of normal activity missed, 28, 56, 60 and childcare. 67 To note, days of normal activity missed was costed using either a percentage of annual wage, 60 or a national average wage tariff; 56 the third study did not state the tariff applied. 28 Health service perspective. Of the 20 studies that conducted the analysis from the health service perspective, all captured costs related to health care utilization and 12 (60%) reported costs due to intervention delivery. As illustrated in Table 4 , there is substantial variance within each cost component regarding the types of cost variables that were captured. For example, primary care physician/ general practitioner was the most commonly captured variable within the health care utilization category, yet only 57% (n = 21) of the societal perspective studies, and 50% (n = 10) of the health service perspective studies reported it. This further highlights not only a lack of consistency in societal costs recorded but also in the more narrow health service perspective costs.
Cost Measurement Tools
Due to incomplete reporting in some studies, it was difficult to ascertain why some costs were not recorded. It may societal perspective, with the remainder (35%, n = 20) from a health service perspective. However, 19 (33%) studies did not explicitly state the perspective used, which was deduced by the reviewers based on reported outcomes as recorded in Table 2 . Eight studies conducted a cost analysis from both perspectives, the details of which are shown in Table 3 . These studies usefully reveal the influence of the analytical perspective on cost-effectiveness estimates. Generally, the analytic perspective did not impact cost-effectiveness; if the intervention was found to be either cost-effective or not cost-effective, it remained true regardless of the perspective.
There was one notable example in which the choice of perspective influenced the cost-effectiveness results to a considerable degree. Marra et al 57 found that the intervention was cost-effective from both perspectives based on local willingness-to-pay thresholds; the cost per QALY was substantially higher from the societal perspective, $14,395 per QALY gain from the societal perspective in comparison to $431 per QALY gain from the health service perspective. 57 So although the choice of perspective did not alter the conclusions of cost-effectiveness, it led to a very substantial difference in the incremental cost-effectiveness ratio.
Cost Variables Collected by Perspective
The data extracted from the studies showed little consistency and standardization in terms of the collected costs. Table 4 shows the percentage of studies that captured each cost variable. Overall there was a lack of consistency not only in the cost categories that were captured, but also within the cost variables captured within each of these categories. The number of cost items captured within each category ranged from 1 to 23 items between studies. Significantly, this variation in the costs captured was observed both in studies that applied the societal perspective and studies that applied the health service perspective.
Societal perspective.
Of the 37 studies that captured costs from a societal perspective, 33 (89%) captured health a Education (verbal) was any type of advice or recommendations provided to a patient by a therapist. Education (book) was education or information in a booklet about how to manage chronic musculoskeletal pain. UK = United Kingdom, NS = not specified, GP = general practitioner, US = United States, N/A = not applicable, VAS = visual analog scale, OA = osteoarthritis, CBT = cognitive-behavioral therapy, QALY = quality-adjusted life-years, LBP/NP = low back pain/neck pain, ICER = incremental cost-effectiveness ratio.
Cost Outcomes Reported
Of the 39 studies that reported results, 19 (49%) concluded the intervention was cost-effective/cost-sav ing, 29 found it not to be cost-effective/cost-saving, 24, 32, 36, 38, 44, 51, 56, 59, [63] [64] [65] 68, 72, [85] [86] [87] and 4 (10%) reported varied results that were contingent on other factors. 25, 42, 67, 70 Of the latter, Jensen et al 42 found the self-management intervention to be cost-effective for women but not for men; Whitehurst et al 70 found the brief education self-management intervention to be cost-effective as well as an education Out-of-pocket expenses 22
Over-the-counter medication 22
Days of normal activities missed 8
Informal care 11
Time off work for carer 8
Nonmedical activities 8
Child care 3
Time in treatment/health promotion 11 covered in all studies to enhance comparability. 12 The first known published quality checklist for economic evaluations was in 1992. 92 The more commonly used checklists are the Drummond checklist published in 1999 and the Evers checklist in 2005. 93 Interestingly, even though no limit on study year was imposed in our search, all reviewed studies were from 1992 onward. Accordingly, nearly the entire sample was published since the publication of Drummonds' initial checklist and the majority since Evers' checklist. As expected, considering the recent emphasis on the importance of economic evaluations by funding bodies and funders of health care, the majority of studies have been conducted since 2010. However, there is no evident trend in terms of the more recent studies being more rigorous in their methodologies. For example, some of the most detailed costings were conducted by a 1999 study (29 cost items), 51 2009 study (25 cost items), 64 and 2011 study (20 cost items), 27 which suggests more specific and detailed guidance on costing is still required.
Although the methodology for the capture of costs is a key component of several quality checklists for conducting economic evaluations, 92 they appear to have had little impact on the costing methodologies used in these studies. This may be because the checklists are insufficiently prescriptive on exactly which costs should be included and the guidelines remain open to substantial subjective interpretation. Questions such as "were all important and relevant costs for each alternative identified?" 13 or "were all costs and consequences measured appropriately in physical units?" 13 are asked across a range of quality checklists; however, without standardization of what should be measured and how to measure them, the answers to these questions will continue to remain subjective and may not enhance the quality of the studies and the reliability of the results.
Finally, the review found that the measurement of effect tended to be more consistent than the measurement of costs, although some variability was apparent.
care were not widely captured in the studies included in this review. Additionally, research that explored barriers to self-management found the burden of participation in self-management is heavy for people with chronic conditions: some of the key barriers identified were financial problems due to reduced working hours in addition to the cost of making lifestyle changes and attending the intervention. 90 Further effort needs to be made to consistently and comprehensively capture these types of costs in order to explore whether they could impact overall cost-effectiveness conclusions.
Interestingly, a lack of consistency in capturing costs was also found in studies limited to the health service perspective. For example, some studies only captured physician visits, 52 or medication, 49 whereas others reported over 20 cost variables within the health care utilization category, 51 which has implications for the interpretation of results. Future research needs to be consistent regarding the health care costs captured in these analyses in order to generate reliable evidence. An expert group for CEAs in osteoarthritis recommended capturing all relevant resource use, as well as the use of national standardized cost lists for different treatments where available. 91 However, these currently do not exist for self-management interventions specifically.
One key challenge identified from this review was the lack of clarity within studies concerning the omission of certain cost variables either due to their irrelevance or oversight. This is because studies typically do not give a rationale for the inclusion and omission of costs, and there is variability in the cost measurement tools used. The majority of studies captured costs using a study-derived self-report questionnaire not previously used or validated. Moreover, many of these studies did not provide access to the measurement tool in a supplementary appendix. This echoes previous research that highlighted the variation in cost assessment tools used in rheumatic diseases, and proposed the development of a disease-specific cost assessment instrument to ensure a standard list of cost domains to be plus exercise intervention to be cost-effective, but found the intensive cognitive behavioral therapy intervention not cost-effective; Strong et al 67 found that a group self-management intervention led by a psychologist was cost-effective but a lay-led group self-management intervention was not cost-effective; finally, Allen et al 25 stated the self-management intervention was cost-effective but did not report the estimates to support the conclusion. Considering the variability of costs captured and effects used, and the heterogeneity of the interventions, comparators, and contexts, little consensus is observed regarding the cost-effectiveness of self-management from these results.
Discussion
This review found a lack of consistency and standardization in the assessment of cost in health economic analyses of self-management interventions for CMP. Although there is an ongoing debate in economic literature over which perspective is most appropriate, it is difficult to explore the impact of each perspective on overall cost-effectiveness given the lack of consistency among studies in what is captured within each perspective in relation to self-management of CMP. This lack of standardization has an impact on the comparability and transferability of CEA results, which in part may explain the lack of consensus on the cost-effectiveness of self-management interventions, although it is important to note that the heterogeneity of interventions, comparators, and health systems also plays a substantial role in CEA outcomes.
Although the majority of included studies captured the societal perspective, cost variables collected within the perspective varied, which poses a challenge for interpreting CEA results. Chronic musculoskeletal pain conditions and self-management can incur substantial costs that fall outside the health system. For instance, in a review of cost of illness studies of OA, investigations from Belgium, Italy, Spain, and the Netherlands found that broader societal costs such as productivity losses and informal care represented between 36% and 83% of total care costs for this condition. 89 Yet costs such as informal the type of CMP. Self-management is not a curative intervention and instead aims to assist people in managing these symptoms on an ongoing basis for the remainder of their lives. Thus it is important, in order to gain a comprehensive understanding of the long-term cost-effectiveness of these interventions, that studies are conducted which capture the fluctuating nature of both cost and benefit outcomes over the lifetime of the condition.
Limitations
This review has a number of limitations. First, only peer-reviewed research was considered and gray literature was not searched, which may have compromised the comprehensiveness of the search strategy, as potentially relevant economic evaluations published in non-peer review formats have not been included. Second, to optimize the specificity of the search, the review focused solely on CMP conditions where self-management was considered a primary treatment recommendation, but excluded other CMP conditions where self-management was recommended, but not as a primary treatment. For example, conditions such as rheumatoid arthritis and ankylosing spondylitis were excluded as they form distinct patient populations and require different management strategies to other CMP conditions. 94 Although self-management can be recommended for these types of conditions, the primary treatment strategy generally includes specialist care, pharmacological management, and manual therapy. 94 Third, while every effort was made to access appendices and supplementary material, authors were not contacted to request copies of the measurement tools used and thus this review is solely based on published material. 15 Completing this inventory in conjunction with this review will increase transparency as the inventory requires the authors to explicitly note when a cost item has not been included. This will ensure that authors have provided a detailed rationale for the inclusion of costs and demonstrate they have considered all possible costs and benefits relating to self-management for CMP.
• Second, the Second Panel on Cost-Effectiveness in Health and Medicine recently updated their CEA guidelines, which were first published 20 years ago. 15 A significant feature of the updated guidelines is the recommendation that all future economic evaluations should report CEA results from both the health service and societal perspectives. These guidelines are also in line with recent recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis. 91 Thus all future economic evaluations of self-management for CMP should conduct separate analyses from both the health service perspective and societal perspective, regardless of national guidelines on CEAs. 15, 91 • Third, all future studies should state and reference their country's current economic evaluation guidelines on choosing an analytical perspective. This will provide detail on the decision making context and will increase transparency as to why the perspective/perspectives were chosen.
• Finally, there is a need for further economic modeling studies that can simulate the longer-term outcomes of self-management for CMP. Chronic musculoskeletal pain is a lifelong condition and an individual can experience periods of flare-up or progressive deterioration depending on
The majority of studies captured QALYs using a generic quality of life measure, which is to be expected considering the QALY is the standard measure of effect for economic evaluations. The QALY is used in economic evaluations for 2 key reasons; first it allows for comparability between different interventions for different conditions, which assists decision makers in the appropriate allocation of health care resources. Second, willingness to pay thresholds, against which the cost-effectiveness of interventions is determined, are expressed in cost per QALY gained. However, several studies in this review used other measures of effect; for example, 8 studies used a change in a disease-specific measure to capture effectiveness rather than using a QALY. 25, 26, 35, 40, 43, 45, 48, 51, 57 Using a disease-specific measure inhibits the ability to compare CEA results to the cost-effectiveness threshold, and thus cost-effectiveness cannot be determined. This leads to issues of comparability, and potentially compromises the usefulness of CEAs. Therefore, it is important that future studies report CEA results using QALYs.
Implications
Although research from over 10 years ago has highlighted the need for standardization of the assessment of costs in musculoskeletal diseases, 11 the findings from this review clearly show that considerable variability still exists. This review is timely, as there have been recent efforts to develop a reference case for economic evaluations of certain CMP conditions to standardize methodological approaches. 91 There are 4 key recommendations generated from this review to assist in improving the quality and rigor of future studies in this area.
• First, standardization of cost variables captured from both the health service perspective and societal perspective is needed to increase consistency and comparability of future studies. It is recommended that studies refer to the list of cost components outlined in this review (Tab. 4) as a guide to the types of costs that should potentially be in-evidence of self-management is to be generated. This would also provide greater clarity concerning the most appropriate perspective for health economic evaluations of self-management interventions.
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4 European Bone and Joint Health Strategies Group. European action towards better musculoskeletal health: a guide to the prevention and treatment of musculoskeletal conditions for the healthcare practitioner and policy maker. 2005.
were captured in some studies. Nevertheless, it is an important finding from the review that studies need to be more explicit in terms of the costs measured and incurred.
Finally, a quality assessment of included studies was not completed as part of this review. Conducting quality assessments of economic evaluations can be problematic. Previous research has found that instruments for assessing the quality of economic evaluations have poor inter-rater reliability and results of quality assessments were more influenced by the assessor than by the instrument itself. 95 A possible reason could be that quality checklists may be insufficiently prescriptive and thus open to substantial subjective interpretation by assessors. The aim of this review was to explore methodologies employed in this field particularly relating to the costs and effects captured and the perspective chosen, but unfortunately, as we were unable to identify a checklist that was sufficiently prescriptive to address these key areas of quality, the inclusion of a quality checklist added little value. Although the review provided a critical assessment of current activity in economic evaluations of self-management for CMP, the lack of formal quality assessment prevented a discussion of the differences in methodological quality across the societal and health service perspective. This precluded our ability to comment on the quality of evidence contributing to the synthesis of results.
Conclusions
The review found substantial heterogeneity in the cost components captured in the assessment of self-management for CMP, independent of the analytic perspective employed. Although the analytical perspective applied had no impact on conclusions regarding the intervention's cost-effectiveness, the variability in the costs captured within each perspective limits the conclusions that can be drawn from this result. The variability in costs also compromises general conclusions on the cost-effectiveness of self-management for CMP. Thus greater efforts to ensure complete and consistent costings are required by researchers if reliable cost-effectiveness
